{"protocolSection": {"identificationModule": {"nctId": "NCT03014180", "orgStudyIdInfo": {"id": "IPTL01"}, "organization": {"fullName": "LivaNova", "class": "INDUSTRY"}, "briefTitle": "Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm (LEVEA)", "officialTitle": "Clinical Evaluation of LEft VEntricular Auto Threshold Algorithm", "acronym": "LEVEA"}, "statusModule": {"statusVerifiedDate": "2018-09", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-02-16", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2017-08-17", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-08-17", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-10-11", "studyFirstSubmitQcDate": "2017-01-05", "studyFirstPostDateStruct": {"date": "2017-01-09", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-09-20", "resultsFirstSubmitQcDate": "2019-02-13", "resultsFirstPostDateStruct": {"date": "2019-05-28", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-02-13", "lastUpdatePostDateStruct": {"date": "2019-05-28", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "LivaNova", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "The purpose of the LEVEA study is to assess the performances of a new automatic left ventricular auto threshold (LVAT) algorithm (In-Clinic LVAT algorithm) when used by physicians during in-hospital follow-up.", "detailedDescription": "\"In-Clinic LVAT\" feature is a non CE-marked feature designed to be activated by the physician during 2 hospital follow-ups:\n\n* first visit: planned to be conducted 15 days maximum after inclusion\n* second visit: planned to be conducted between 1 and 3 months after the first visit The evaluation consists in the comparison between the threshold value provided by the algorithm and the threshold value obtained manually by the physician."}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Heart failure, CRT"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 60, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "\"In-Clinic LVAT\"", "type": "EXPERIMENTAL", "description": "All subject prior to study enrollment has been implanted with a CRT-D device. During follow-ups, under the supervision of the physician, the algorithm embeded in the device is activated with a password. The feature is deactivated at the end of each follow-up.", "interventionNames": ["Device: \"In-Clinic LVAT\""]}], "interventions": [{"type": "DEVICE", "name": "\"In-Clinic LVAT\"", "description": "Algorithm offers automatic threshold measurement of differents vectors of left ventricular stimulation.", "armGroupLabels": ["\"In-Clinic LVAT\""], "otherNames": ["Activation of an algorithm in CRT-D device"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Percentage of Successful\"In-Clinic LVAT\" Test", "description": "The success rate is defined as the equivalence between the value measured by the algorithm and the measure obtained manually by the physician on 5 identified pacing vectors during the visit among at least 231 LV tests.", "timeFrame": "0-3 months post inclusion"}], "secondaryOutcomes": [{"measure": "Percentage of Accurate \"In-Clinic LVAT\" Test Assessed by an Independent Reviewer", "description": "This endpoint is the number of accurate determination of the pacing threshold value provided by the algorithm feature and an independent reviewer, on all available LV pacing vectors at first visit.\n\nAn independent reviewer assessed all LV pacing threshold values provided by the algorithm at M0 visit and in all tested configurations", "timeFrame": "0-15 days post inclusion"}, {"measure": "Percentage of Successful of \"In-Clinic LVAT\" Test at M0 Visit", "description": "The success rate of \"In-Clinic LVAT\" feature for all available LV pacing vectors at first follow-up (M0 visit). The method of analysis is similar to the primary endpoint.", "timeFrame": "0-15 days post inclusion"}, {"measure": "Percentage of Successful \"In-Clinic LVAT\" Test at M1 Visit", "description": "The success rate of \"In-Clinic LVAT\" feature for all available LV pacing vectors at second follow-up . The method of analysis is similar to the primary endpoint", "timeFrame": "1-3 months after first visit"}, {"measure": "Percentage of Eligible Subjects to LVAT Feature", "description": "Identification of the number of subjects who were \"eligible\" to receive the feature at M0 or M1 visit", "timeFrame": "0-3 months post inclusion"}, {"measure": "Safety of the LVAT Algorithm", "description": "Reporting of SAEs, device deficiencies and any suspect behaviour of the algorithm.", "timeFrame": "0-3 months post inclusion"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Subject already implanted (de-novo, upgrade or replacement) according to the relevant ESC Guidelines \\[1\\]:\n\n  * With IS1 Platinium SonR CRT-D (models 1811, 1841, CE-marked) for maximum of 5 days or;\n  * With IS4 Platinium SonR CRT-D (model 1844, CE-marked).\n* Right atrial, right and left ventricular leads must be implanted. Only bipolar and quadripolar for Left Ventricular lead.\n* Reviewed, signed and dated informed consent.\n\nExclusion Criteria:\n\n* Subject included in another clinical study that could confound the results of this study;\n* Malfunction or dislodgment of right atrial, right and left ventricular implanted leads;\n* Subject diagnosed with permanent atrial fibrillation;\n* Known pregnancy;\n* Minor age;\n* Under protection or guardianship;\n* Unavailability for scheduled follow-up or refusal to cooperate", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Jacques Mansourati, Pr", "affiliation": "CHRU de Brest, FRANCE.", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "CHRU Brest", "city": "Brest", "zip": "29609", "country": "France", "geoPoint": {"lat": 48.3903, "lon": -4.48628}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "All the 60 patients were assigned to the treatment arm.", "recruitmentDetails": "Subjects have been included from Feb 16, 2017 to June 2, 2017.", "groups": [{"id": "FG000", "title": "\"In-Clinic LVAT\"", "description": "60 patients were included in the single-arm study. The Left Ventricular auto threshold (LVAT) algorithm test was performed at the 2 study visits M0 and M1."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "60"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "58"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}]}], "dropWithdraws": [{"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "\"In-Clinic LVAT\"", "description": "Single-arm study design: all the 60 patients were assigned to the treatment arm."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "60"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "68.4", "spread": "8.97"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "16"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "44"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "60"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "France", "categories": [{"measurements": [{"groupId": "BG000", "value": "43"}]}]}, {"title": "Spain", "categories": [{"measurements": [{"groupId": "BG000", "value": "9"}]}]}, {"title": "Germany", "categories": [{"measurements": [{"groupId": "BG000", "value": "8"}]}]}]}, {"title": "Type of device implanted", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "IS1", "categories": [{"measurements": [{"groupId": "BG000", "value": "24"}]}]}, {"title": "IS4", "categories": [{"measurements": [{"groupId": "BG000", "value": "36"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Percentage of Successful\"In-Clinic LVAT\" Test", "description": "The success rate is defined as the equivalence between the value measured by the algorithm and the measure obtained manually by the physician on 5 identified pacing vectors during the visit among at least 231 LV tests.", "populationDescription": "Complete LV vector test: test was performed (not aborted or interrupted) and a threshold value is provided by the algorithm.\n\nSuccessful LV Vector Test: LV threshold value provided by the algorithm compared to the manual threshold is considered \"Successful\" if the difference is within \u00b1 2 step", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "percentage of successful LVAT test", "timeFrame": "0-3 months post inclusion", "typeUnitsAnalyzed": "Completed LV vector tests", "denomUnitsSelected": "Completed LV vector tests", "groups": [{"id": "OG000", "title": "In-clinic LVAT", "description": "Patients assigned to the single-arm treatment LVAT. LVAT test performed at M0 and M1 visits."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}]}, {"units": "Completed LV vector tests", "counts": [{"groupId": "OG000", "value": "262"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "94.66", "lowerLimit": "90.66", "upperLimit": "97.31"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Accurate \"In-Clinic LVAT\" Test Assessed by an Independent Reviewer", "description": "This endpoint is the number of accurate determination of the pacing threshold value provided by the algorithm feature and an independent reviewer, on all available LV pacing vectors at first visit.\n\nAn independent reviewer assessed all LV pacing threshold values provided by the algorithm at M0 visit and in all tested configurations", "populationDescription": "Completed LV Vector Test: test was performed (not aborted or interrupted) and a threshold value is provided by the algorithm.\n\nAccurate LV Vector Test: The LV threshold value provided by the algorithm compared to the reviewer assessment is considered accurate if the difference is within \u00b1 1 step.", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of accurate determination", "timeFrame": "0-15 days post inclusion", "typeUnitsAnalyzed": "Number of completed LV Vector Tests", "denomUnitsSelected": "Number of completed LV Vector Tests", "groups": [{"id": "OG000", "title": "In-clinic LVAT", "description": "Patients assigned to the single-arm treatment LVAT. LVAT test performed at M0 visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}]}, {"units": "Number of completed LV Vector Tests", "counts": [{"groupId": "OG000", "value": "1301"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "99.31", "lowerLimit": "98.59", "upperLimit": "99.72"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Successful of \"In-Clinic LVAT\" Test at M0 Visit", "description": "The success rate of \"In-Clinic LVAT\" feature for all available LV pacing vectors at first follow-up (M0 visit). The method of analysis is similar to the primary endpoint.", "populationDescription": "Completed LV vector Test: test was performed (not aborted or interrupted) and a threshold value is provided by the algorithm.\n\nSuccessful LV Vector Test: LV threshold value provided by the algorithm compared to the manual threshold is considered \"Successful\" if the difference is within \u00b1 2 steps", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Percentage of successful LVAT test", "timeFrame": "0-15 days post inclusion", "typeUnitsAnalyzed": "Number of completed LV Vector Tests", "denomUnitsSelected": "Number of completed LV Vector Tests", "groups": [{"id": "OG000", "title": "In-clinic LVAT", "description": "Patients assigned to the single-arm treatment LVAT at M0 visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "55"}]}, {"units": "Number of completed LV Vector Tests", "counts": [{"groupId": "OG000", "value": "1193"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "90.86", "lowerLimit": "88.82", "upperLimit": "92.65"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Successful \"In-Clinic LVAT\" Test at M1 Visit", "description": "The success rate of \"In-Clinic LVAT\" feature for all available LV pacing vectors at second follow-up . The method of analysis is similar to the primary endpoint", "populationDescription": "Completed LV Vector Test: test was performed (not aborted or interrupted) and a threshold value is provided by the algorithm.\n\nSuccessful LV Vector Test: LV threshold value provided by the algorithm compared to the manual threshold is considered \"Successful\" if the difference is within \u00b1 2 steps", "reportingStatus": "POSTED", "paramType": "NUMBER", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Pecentage of successful LVAT test", "timeFrame": "1-3 months after first visit", "typeUnitsAnalyzed": "Number of completed LV Vector Tests", "denomUnitsSelected": "Number of completed LV Vector Tests", "groups": [{"id": "OG000", "title": "In-clinic LVAT", "description": "Patients assigned to the single-arm treatment LVAT at M1 visit."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "56"}]}, {"units": "Number of completed LV Vector Tests", "counts": [{"groupId": "OG000", "value": "1217"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "92.03", "lowerLimit": "90.12", "upperLimit": "93.68"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Eligible Subjects to LVAT Feature", "description": "Identification of the number of subjects who were \"eligible\" to receive the feature at M0 or M1 visit", "populationDescription": "Eligible subjects: Number of subjects with at least one complete LV Vector Test at M0 or M1 visits", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Percentage of eligible subjects", "timeFrame": "0-3 months post inclusion", "groups": [{"id": "OG000", "title": "In-clinic LVAT", "description": "Patients assigned to the single-arm treatment LVAT. LVAT test performed at M0 and M1 visits."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "57"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "98.25"}]}]}]}, {"type": "SECONDARY", "title": "Safety of the LVAT Algorithm", "description": "Reporting of SAEs, device deficiencies and any suspect behaviour of the algorithm.", "populationDescription": "Included population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Event", "timeFrame": "0-3 months post inclusion", "groups": [{"id": "OG000", "title": "Secondary Endpoint", "description": "All serious adverse events and device deficiency during in-clinic LVAT test."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "60"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "0-3 months post inclusion", "description": "SAE and device deficiency were collected through the study duration and AE was collected at each study visit.", "eventGroups": [{"id": "EG000", "title": "In-Clinic LVAT", "description": "All serious adverse events and device deficiency during in-clinic LVAT test.", "deathsNumAffected": 0, "deathsNumAtRisk": 60, "seriousNumAffected": 6, "seriousNumAtRisk": 60, "otherNumAffected": 0, "otherNumAtRisk": 60}], "seriousEvents": [{"term": "Cardiac decompensation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 60}]}, {"term": "Heart failure worsening", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 60}]}, {"term": "Bleeding", "organSystem": "Injury, poisoning and procedural complications", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 60}]}, {"term": "Embolization", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 60}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "LTE60", "restrictiveAgreement": true}, "pointOfContact": {"title": "Director of Scientific Communication", "organization": "Microport CRM", "email": "anne.rousseauplasse@crm.microport.com", "phone": "0677164209"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2016-09-29", "uploadDate": "2018-09-20T11:32", "filename": "Prot_000.pdf", "size": 1226544}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2018-04-20", "uploadDate": "2018-09-20T11:33", "filename": "SAP_001.pdf", "size": 989927}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}